Accugenomics, INC.
Doing business as Accugenomics
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersWilmington, NC
US patents1
SAM.gov UEIYCHWLVCESG77
CAGE code68MP8
Incorporated inNC
- Mammo DNA
- CRC/NSCLC
- Myeloid DNA
- Onco1 LB
- SARS-CoV-2
- adventitious agents
- commercial-stage molecular diagnostic
- co-development
- RNA sequencing
- spike-in controls
- next generation sequencing
Named on the company’s own website, read JUL 29, 2026
Supplier designations
For Profit OrganizationManufacturer of Goods
Self-certified by the company in its SAM.gov registration
Patents
1 US patent granted AUG 23, 2022.
Biotechnology 1
- Nucleic acid amplification and use thereofUS 11,421,267 · granted AUG 23, 2022
Granted to Accugenomics, Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Accugenomics, INC. | Wilmington | NC | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.